pg-760564
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00791817)
Timeline
Indications
Mechanism of action
- MAP kinase p38 alphaINHIBITOR
MAPK14 inhibitor
No assay data or further target information found
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545398 ↗
Also known as
- pg-760564
- pg-760564
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00369928 | Phase 2 | Aug 1, 2006 | Procter and Gamble |
| NCT00791388 | Phase 1 | Aug 1, 2005 | Procter and Gamble |
| NCT00791817 | Phase 1 | Aug 1, 2005 | Procter and Gamble |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Procter and Gamble | For profit | 3 | 3 | 2 | 2005 |
1 organizations
Page 1 / 1